News blog

Avisen / Cantono

  • BY: Andrew Hore |
  • POSTED: 13/10/2010 |

Costs relating to the merger with Xploite mask the progress that performance management consultancy and software provider Avisen is making in its core business. 

Growth Equities & Company Research believes that Avisen could make a pre-exceptional profit of £1.4m in the year to January 2011 but that would not be obvious from looking at the interims.

Revenues increased from £1.73m to £6.05m in six months to July 2010. Xploite has little in the way of revenues and most of that improvement came from Inca which was bought in July 2009. The inclusion of Inca means that 23% of revenues are recurring.

The reported interim loss increased from £2.75m to £6.27m. That includes £6.22m of one-off costs and write-offs mainly related to Xploite. There have been £1m of annualised cost savings since April. Net debt was £148,000 at the end of July 2010.

Avisen has come to an agreement with the administrator of Cantono about the cash owed by Xploite to Cantono relating to the purchase of the former’s managed services businesses. The original deferred consideration was £1.1m (due on 15 March 2009) but the administrator was suing for £4.54m. The final agreement is for a payment of £300,000 plus a possible £300,000 more under certain circumstances including a disposal. Settling this is likely to put Avisen in the good books of institutional shareholders of Cantono, which were not happy with Xploite.

The merger with Xploite was at best a diversion from the main business. It did come with cash but much of that has gone to pay off the costs of the deal. It is possible that storage analytics company Storage Fusion, which is currently loss-making, could become a valuable asset in the future but management needs to move it into profit first. 

At 5.25p a share, up 0.5p, Avisen is valued at £11.9m. The shares are trading on less than seven times forecast 2010-11 earnings.

Second quarter trading was particularly strong and this rate of trading is continuing into the second half. Pharma is a particularly strong sector and the public sector is not a significant customer. “We are in a very good spot”, says chief executive Marcus Hanke.

Download the October edition of AIM Journal at http://www.hubinvest.com/AIMPDFOctober2010_13.pdf

© 2024 Aim Micro. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Browse by issue
All issues
Popular tags
All tags

betbrokers, financial, gold, health, leisure, media, mobile, resources, services, technology

AIM Micro feeds

Keep up to date with articles published at AIMMicro.com. Subscribe to AIM Micro RSS Feeds